INPP5E (Inositol Polyphosphate-5-Phosphatase E) is a 72 kDa enzyme that hydrolyzes phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P3) and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) . Key roles include:
Mutations in INPP5E are linked to Joubert syndrome and MORM syndrome, characterized by neurological, renal, and developmental abnormalities .
The INPP5E antibody is widely used in:
INPP5E antibody staining revealed its concentration at immune synapses in Jurkat T-cells, where it interacts with CD3ζ, ZAP-70, and Lck to sustain T-cell receptor (TCR) signaling .
Silencing INPP5E disrupts CD3ζ polarization, reduces interleukin-2 secretion, and impairs PI(4,5)P2 clearance .
INPP5E knockdown (validated via antibody-based assays) enhances herpes simplex virus infection by altering actin remodeling and viral attachment .
INPP5E antibody localization studies show its presence at centrosomes, kinetochores, and spindle midzones during mitosis, where it prevents aneuploidy .
Joubert Syndrome: INPP5E antibodies help identify loss-of-function mutations in patient-derived cells .
Cancer Research: INPP5E is upregulated in cervical cancer and lymphomas but downregulated in gastric carcinomas, highlighting its dual role in tumorigenesis .
Validation: Ensure specificity using knockout controls (e.g., INPP5E-null cell lines) .
Cross-Reactivity: Verify reactivity across species (human, mouse, rat) .
Storage: Stable at -20°C in aliquots to prevent freeze-thaw degradation.
INPP5E (inositol polyphosphate-5-phosphatase, 72 kDa) is a critical enzyme involved in phosphoinositide metabolism that regulates various cellular processes. Recent studies have identified it as a key player in the phosphoinositide manipulation at immune synapses, controlling TCR signaling cascades . INPP5E has a calculated molecular weight of 644 amino acids and approximately 70 kDa, though it is often observed at 64-66 kDa in experimental conditions . Its importance extends to primary cilia function, with mutations being associated with ciliopathies.
Current research applications utilize several antibody formats targeting INPP5E:
Polyclonal antibodies (e.g., rabbit polyclonal IgG) that recognize multiple epitopes
Monoclonal antibodies (e.g., mouse IgG1) that provide highly specific single-epitope binding
Antibodies targeting different regions of INPP5E, including:
Selection should be based on:
INPP5E antibodies have been validated in diverse biological samples, with specific positive results in:
For rigorous experimental design, implement the following controls:
Positive controls: Utilize tissues/cells with known INPP5E expression (e.g., HEK-293 cells, mouse brain tissue)
Negative controls:
Specificity controls: Secondary antibody-only controls to detect non-specific binding, which has been observed in both T cells and APCs in immune synapse studies
Different INPP5E antibody formulations require specific storage conditions:
Standard formulations: Store at -20°C with PBS containing 0.02% sodium azide and 50% glycerol (pH 7.3). Stable for one year after shipment
Conjugation-ready formulations: Store at -80°C in PBS-only buffer (BSA and azide-free) at 1 mg/mL concentration
For standard formulations, aliquoting is unnecessary for -20°C storage
Recent research has revealed dynamic INPP5E distribution during immune synapse formation:
INPP5E signals appear faintly at the immune synapse 2 minutes after T cell-APC conjugation
In resting cells, INPP5E localizes to centrioles, but relocates toward the immune synapse upon stimulation
For optimal visualization, immunostaining combined with 3D-structured illumination microscopy (3D-SIM) provides detailed spatial resolution
Effective validation requires multi-parameter assessment:
Western blot: Confirm depletion of INPP5E signal at approximately 70 kDa compared to control cells
Immunofluorescence: Assess reduction in INPP5E enrichment at centrioles in resting cells
Functional assays: Measure decreased INPP5E polarization toward the immune synapse (e.g., reduced from 71.52% in control cells to 38.09% in knockdown cells)
Quantification: Express results as percentage of conjugation events showing proper localization
For accurate colocalization analysis:
Employ triple-staining techniques with INPP5E antibody and known cellular markers
Utilize super-resolution microscopy (e.g., 3D-SIM) for precise spatial mapping
For centriole/basal body localization, combine with centrosomal markers
For immune synapse studies, measure polarization toward the T cell-APC interface
Quantify colocalization using appropriate software and statistical metrics (Pearson's correlation, Manders' overlap coefficient)
While the calculated molecular weight of INPP5E is 70 kDa (644 amino acids), Western blot typically detects it at 64-66 kDa . This discrepancy may result from:
Post-translational modifications affecting protein migration
Proteolytic processing in specific cell types
Secondary/tertiary protein structure influencing SDS-PAGE mobility
Alternative splicing generating different isoforms
The consistent observation across multiple studies suggests this is a normal characteristic rather than an experimental artifact.
Non-specific binding has been reported in both T cells and APCs . To improve signal specificity:
Titrate antibody concentration (recommended range: 1:20-1:200)
Extend blocking time with 5% BSA or serum matching secondary antibody host
Include 0.1-0.3% Triton X-100 for improved penetration
Consider antigen retrieval optimization (TE buffer pH 9.0 or citrate buffer pH 6.0)
Employ confocal microscopy with appropriate negative controls
Use fluorophore-conjugated secondary antibodies with minimal spectral overlap
When analyzing INPP5E distribution during processes like immune synapse formation:
Account for temporal dynamics (signals increase 2-10 minutes after cell conjugation)
Consider multiple z-stacks to capture the complete 3D distribution
Recognize that antibody accessibility may vary between cellular compartments
Compare localization patterns with known INPP5E interaction partners
Analyze multiple time points to establish the sequence of recruitment events
Quantify signal intensity changes across experimental conditions
Recent discoveries highlight INPP5E as a novel regulator of T cell function:
It participates in phosphoinositide manipulation at the synapse, controlling TCR signaling cascades
Knockdown experiments demonstrate its critical role in immune synapse formation events
The spatial-temporal distribution of INPP5E during immune synapse formation follows a specific pattern, appearing 2 minutes after conjugation and increasing 5-10 minutes after conjugation
Cutting-edge approaches include:
Super-resolution microscopy, particularly 3D-structured illumination microscopy (3D-SIM), for detailed visualization of INPP5E localization
Matched antibody pairs developed specifically for cytometric bead arrays and multiplex assays
Conjugation-ready antibody formats allowing flexible application in ELISAs, multiplex assays, mass cytometry, and multiplex imaging
Combined knockdown and live cell imaging approaches to track dynamic INPP5E redistribution
For comprehensive signaling studies:
Combine INPP5E antibodies with phosphoinositide sensors to correlate enzyme localization with substrate dynamics
Utilize matched antibody pairs for multiplexed detection in complex samples
Integrate INPP5E research with investigation of interacting partners identified through co-immunoprecipitation studies
Apply systems biology approaches to position INPP5E within larger phosphoinositide metabolism networks
Correlate INPP5E activity with downstream signaling events such as TCR cascade activation